The global Cancer Biomarkers market is estimated to be valued at US$ 21,643.9 million in 2022 and is expected to exhibit a CAGR of 14.4% over the forecast period, as highlighted in a new report published by Coherent Market Insights. A) Market Overview:The Cancer Biomarkers Market includes various products used for the detection and monitoring of cancer, such as diagnostic tests, imaging...